[1] MASI A,DEMAYO M M,GLOZIER N,et al.An overview of autism spectrum disorder,heterogeneity and treatment options[J].Neurosci Bull,2017,33(2):183-193.
[2] American Psychiatric Association.Diagnostic and statistical manual of mental disorders[M].5th ed.Washington:American Psychiatric Association，2013.
[3] MANNION A,LEADER G.An investigation of comorbid psychological disorders,sleep problems,gastrointestinal symptoms and epilepsy in children and adolescents with autism spectrum disorder:a two year follow-up[J].Res Autism Spectr Disord,2016,22(27):20-33.
[4] HUANG J,DU C,LIU J,et al.Meta-analysis on intervention effects of physical activities on children and adolescents with autism[J].Int J Environ Res Public Health,2020,17(6):1950
[5] RODDY A,O'
NEILL C.The economic costs and its predictors for childhood autism spectrum disorders in Ireland:how is the burden distributed[J].Autism,2019,23(5):1106-1118.
[6] 中华医学会儿科学分会发育行为学组.孤独症谱系障碍儿童早期识别筛查和早期干预专家共识[J].中华儿科杂志,2017,55(12):890-897.
[7] YATAWARA C J,EINFELD S L,HICKIE I B,et al.The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism:a randomized clinical crossover trial[J].Mol Psychiatry,2016,21(9):1225-1231.
[8] WOLFF J J,SWANSON M R,ELISON J T,et al.Neural circuitry at age 6 months associated with later repetitive behavior and sensory responsiveness in autism[J].Mol Autism,2017,8(38):2040-2392.
[9] AMORY M,JUDY V D W.The role of the immune system in autism spectrum disorder[J].Neuropsychopharmacology,2017,42(1):284-298.
[10] BAUMAN M D,IOSIF A M,ASHWOOD P,et al.Maternal antibodies from mothers of children with autism alter brain growth and social behavior development in the rhesus monkey[J].Transl Psychiatry,2013,3(7):e278.
[11] MCDOUGLE C J,LANDINO S M,VAHABZADEH A,et al.Toward an immune-mediated subtype of autism spectrum disorder[J].Brain Res,2015,1617:72-92.
[12] MEAD J,ASHWOOD P.Evidence supporting an altered immune response in ASD[J].Immunol Letters,2015,163(1):49-55.
[13] LI Y,MISSIG G,FINGER B C,et al.Maternal and early postnatal immune activation produce dissociable effects on neurotransmission in mPFC-amygdala circuits[J].J Neurosci,2018,38(13):3358-3372.
[14] GRAHAM A M,RASMUSSEN J M,RUDOLPH M D,et al.Maternal systemic interleukin-6 during pregnancy is associated with newborn amygdala phenotypes and sub-sequent behavior at 2 years of age[J].Biol Psychiatry,2018,83(2):109-119.
[15] HAFIZI S,TABATABAEI D,LAI MC.Review of clinical studies targeting inflammatory pathways for individuals with autism[J].Front Psychiatry,2019,10(3):849.
[16] CONNERY K,TIPPETT M,DELHEY LM,et al.Intravenous immunoglobulin for the treatment of autoimmune encephalopathy in children with autism[J].Transl Psychiatry,2018,8(1):148.
[17] MCDONALD C A,FAHEY M C,JENKIN G,et al.Umbilical cord blood cells for treatment of cerebral palsy; timing and treatment options[J].Pediatric Res,2018,83(1):333-344.
[18] SHAHADUZZAMAN M,GOLDEN J E,GREEN S,et al.A single administration of human umbilical cord blood T cells produces long-lasting effects in the aging hippocampus[J].Age,2013,35(6):2071-2087.
[19] CHO K H,CHOI J I,KIM J O,et al.Therapeutic mechanism of cord blood mononuclear cells via the IL-8-mediated angiogenic pathway in neonatal hypoxic-ischaemic brain injury[J].Sci Rep,2020,10(2):2045-2322.
[20] ROMANOV Y A,VTORUSHINA V V,DUGINA T N.Human umbilical cord blood serum/plasma:cytokine profile and prospective application in regenerative medicine[J].Bull Exp Biol Med,2019,168(1):173-177.
[21] CHEZ M,LEPAGE C,PARISE C,et al.Safety and observations from a placebo-controlled,crossover study to assess use of autologous umbilical cord blood stem cells to improve symptoms in children with autism[J].Stem Cells Transl Med,2018,7(4):333-341.
[22] DAWSON G,SUN J M,DAVLANTIS K S,et al.Autologous cord blood infusions are safe and feasible in young children with autism spectrum disorder:Results of a single-center phaseⅠopen-label trial[J].Stem Cells Transl Med,2017,6(5):1332-1339.
[23] SPARROW S,CICCHETTI D,BALLA D.Vineland Adaptive Behavior Scales (Vineland II):Caregiver/Caregiver Rating Form.2nd ed[J].Minneapolis,2005,35(69):2162-3257.
[24] MALOW B A,CONNOLLY H V,WEISS S K,et al The pediatric sleep clinical global impressions scale-a new tool to,measure pediatric insomnia in autism spectrum disorders[J].J Dev Behav Pediatr,2016,37(5):370-376.
[25] MARTIN NA,BROWNELL R.Expressive one-word picture vocabulary test (EOWPVT-4)[M].4th ed.Novato:Academic Therapy Publications Inc,2011.
[26] MURIAS M,MAJOR S,COMPTON S,et al.Electrophysiological biomarkers predict clinical improvement in an open-label trial assessing efficacy of autologous umbilical cord blood for treatment of autism[J].Stem Cells Transl Med,2018,7(11):783-791.
[27] CARPENTER K L H,MAJOR S,TALLMAN C,et al.White matter tract changes associated with clinical improvement in an open-label trial assessing autologous umbilical cord blood for treatment of young children with autism[J].Stem Cells Transl Med,2019,8(2):138-147.
[28] POUSTKA L,JENNEN-STEINMETZ C,HENZE R et al.Front-temporal disconnectivity and symptom severity in children with autism spectrum disorder[J].World J Biol Psychiatry,2012,13(4):269-280.
[29] TSUJI M,SAWADA M,WATABE S,et al.Autologous cord blood cell therapy for neonatal hypoxic-ischaemic encephalopathy:a pilot study for feasibility and safety[J].Sci Rep,2020,10(14):2045-2322.
[30] SUN J M,GRANT G A,MCLAUGHLIN C,et al.Repeated autologous umbilical cord blood infusions are feasible and had no acute safety issues in young babies with congenital hydrocephalus[J].Pediatr Res,2015,78(6):712-716.
[31] BROWN K S,RAO M S,BROWN H L.The future state of newborn stem cell banking[J].J Clin Med.2019,8;(1):117.
[32] YOUNG P N E,ESTARELLAS M,COOMANS E,et al.Imaging biomarkers in neurodegeneration:current and future practices[J].Alzheimers Res Ther,2020,12(1):49.
[33] RICHARD E F.Behaviorally associated changes in neuroconnectivity following autologous umbilical cord blood infusion in young children with autism spectrum disorder[J].Ann Transl Med,2019,7(Suppl 3):S123.
[34] ROMANOV Y A,TARAKANOV O P,RADAEV S M,et al.Human allogeneic ABO/Rh-identical umbilical cord blood cells in the treatment of juvenile patients with cerebral palsy[J].Cytotherapy,2015,17(7):969-978.
[35] JENSEN A,HAMELMANN E.First autologous cord blood therapy for pediatric ischemic stroke and cerebral palsy caused by cephalic molding during birth:individual treatment with mononuclear cells[J].Case Rep Transplant,2016,2016:1717426. |
